OAKLAND, Calif.–Omicia, the leading clinical genomics company, today announced that it has been selected by Genomics England to provide clinical interpretation services for the 100,000 Genomes Project. For the first phase of the project Illumina will provide sequencing services, while Omicia will provide interpretation and clinical reports. Genomics England leads the UK’s national initiative to […]
The American Society of Clinical Oncology (ASCO) today announced its first-ever clinical trial that will offer patients with advanced cancer access to molecularly-targeted cancer drugs and collect “real-world” data on clinical outcomes to help learn the best uses of these drugs outside of indications approved by the Food and Drug Administration (FDA). Plans for the […]
REDWOOD CITY, California, and FALLS CHURCH, Virginia -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Inova Translational Medicine Institute (ITMI) today announced the commercial launch of Inova Genomes, a unique compendium of ethnically, phenotypically, and ancestrally diverse whole-genome sequencing data for researchers seeking to accelerate cohort analysis programs or improve success rates in […]
MOUNTAIN VIEW, Calif. –- Complete Genomics, Inc., a leader in whole human genome sequencing, today announced that Mater Health Services, a leading Australian health services provider, and Radboud University Medical Center in the Netherlands are to become the first customers for the Revolocity™ sequencing system, the company’s new fully integrated “supersequencer.” The Revolocity system is […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced new additions to its market-leading SureSelect target-enrichment product family, which has already enabled researchers to identify more than 50 Mendelian disease-causing genes. The new products-the SureSelect Human All Exon V6, V6+UTR and V6+COSMIC-are designed to address the current limitations of exome sequencing, giving researchers […]
BOULDER, Colo. — Today ArcherDX expanded its Archer™ FusionPlex™ assay menu to include the FusionPlex Lung Thyroid Panel and FusionPlex Solid Tumor Panel. The two panels are targeted next generation sequencing (NGS)-based assays that can be used to detect gene translocations in clinical samples types. The Lung Thyroid Panel simultaneously detects and characterizes fusions of […]
CARLSBAD, Calif. — A team of scientists that is part of an international, multi-organizational effort to curb further spread of deadly Ebola in Sierra Leone has released their first dataset of the virus’ genetic structure online. The genetic analysis is now on virological.org and available for the global scientific community to monitor the pathogen’s evolution […]
Brazil — Illumina, Inc. (NASDAQ:ILMN) today announced it has named Pensabio, a life science, analytical instruments and diagnostics distributor, headquartered in Sao Paolo, Brazil, as its new distribution partner to deliver Illumina sequencing platforms, products and solutions in Brazil. “Pensabio was selected to distribute Illumina products because of its strong presence and reputation as an […]
CHICAGO — ASCO 2015–Up to 1,000 patients across the United States will be enrolled in a new national oncology clinical trial using genetic sequence information obtained from Thermo Fisher Scientific’s targeted, next-generation sequencing (NGS) technology. Announced today at the American Society of Clinical Oncology (ASCO) annual meeting, the National Cancer Institute- Molecular Analysis for Therapy […]
Framingham, MA — SCIEX, a global leader in life science analytical technologies, today released new innovative LC-MS/MS solutions that will allow scientists around the world to simplify their work, while accelerating their research. New SCIEX innovations include; the BioBA Solution, the first end-to-end solution for bioanalysis of biologics, the Lipidizer™ Platform, the first all-in-one solution […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
